Market Cap | 11.53B | P/E | 12.07 | EPS this Y | - | Ern Qtrly Grth | -20.20% |
Income | 602.6M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -4.00% |
Sales | 16.21B | PEG | - | EPS past 5Y | - | 200D Avg Chg | 3.00% |
Dividend | 13.00% | Price/Book | 2.62 | EPS next 5Y | - | 52W High Chg | -10.00% |
Recommedations | - | Quick Ratio | 1.21 | Shares Outstanding | 721.93M | 52W Low Chg | 44.00% |
Insider Own | - | ROA | 5.36% | Shares Float | 120.74M | Beta | 0.90 |
Inst Own | 0.02% | ROE | 13.94% | Shares Shorted/Prior | -/- | Price | 14.97 |
Gross Margin | 24.61% | Profit Margin | 3.72% | Avg. Volume | 23,145 | Target Price | - |
Oper. Margin | 6.21% | Earnings Date | Nov 12 | Volume | 5,671 | Change | -2.35% |
Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Germany, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber industries. The company was founded in 1874 and is based in Essen, Germany.